Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia

Anticancer Research

Volumn 19, Issue 1 B, 1999, Pages 645-649

  Sauerbrey, A ^a   Hafer R ^a   Zintl, F ^a   Volm, M ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Childhood ALL prognosis; Cyclin D1; Proliferation; Retinoblastoma tumor suppressor gene

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; MESSENGER RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RECURRENCE; CELL PROLIFERATION; CHILD; CHILDHOOD LEUKEMIA; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETINOBLASTOMA; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; BETA 2-MICROGLOBULIN; BONE MARROW CELLS; CELL DIVISION; CHILD; CHILD, PRESCHOOL; CYCLIN D1; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; KI-67 ANTIGEN; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RETINOBLASTOMA PROTEIN; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0344507137     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841-845, 1995.
2. Parwaresch R, Rudolph P: The cell cycle-theory and application to cancer. Onkologie 19: 464-472, 1996.
3. Pines J: Cyclins and cyclin dependent kinases: take your partners. Trends Biochem Sci 18: 195-197, 1993.
4. Morgan DO: Principles of CDK regulation. Science 374: 131-134, 1995.
5. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1063, 1990.
6. Hunter T, Pines J: Cyclins and Cancer. Cell 66: 1071-1074, 1991.
7. Lukas J, Pagano M, Dtaskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9: 707-718, 1994.
8. Paterlini P, Suberville AM, Zindy F, Melle J, Sonnier M, Marie JP, Dreyfus F, Brechot, C: Cyclin A expression in human hematological malignancies: A new marker of cell proliferation. Cancer Res 53: 235-238, 1993.
9. Garcia-Conde J, Cabanillas F: Mantle cell lymphoma: a proliferative disorder associated with aberrant function of the cell cycle. Leukemia 10 (suppl. 2): 78-83, 1996.
10. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57: 353-357, 1994.
11. Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995.
12. Jiang W, Zhang YL, Kahn SM, Hollstein MC, Santella RM, Lu SH, Harris CC, Montesano R, Weinstein IB: Alterated expression of cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90: 9026-9030, 1993.
13. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M, Ishizaki K: Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54: 3107-3110, 1994.
14. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bcl-1-linked candidate oncogene. Nature 350: 512-515, 1991.
15. Withers DA, Harvey RC, Faust JB, Melnyk O, Carey K, Meeker TC: Characterization of a candidate bcl-1 gene. Mol Cell Biol 11: 4846-4853, 1991.
16. Marshall CJ: Tumor suppressor genes. Cell 64: 313-326, 1991.
17. Benedict WF, Xu HJ, Takahash: R Role of the retinoblastoma gene in the initiation and progression of human cancer. J Clin Invest 85: 988-993, 1990.
18. Seto M, Yamamoto K, Iida S, Akao Y, Utsumi KR, Kubonishi I, Miyoshi I, Ohtsuki T, Yawata Y, Namba M, Motokura T, Arnold A. Takahashi T, Ueda R: Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 7: 1401-1406, 1992.
19. Zuckerberg LR, Benedict WF, Arnold A, Dyson N, Harlow E, Harris LH: Expression of the retinoblastoma protein in low-grade B-cell lymphoma: Relationship to cyclin D1. Blood 88: 268-276, 1996.
20. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133, 1993.
21. INK4A) in childhood acute lymphoblastic leukemia. Int J Cancer (Pred. Oncol.) 75: 508-512, 1997.
22. Bennet J M, Catowsky D, Daniel MT, Flandrin G, Galton GAR, Gralnick H R, Sultan C: Proposal for the classification of the acute leukemias. French American British (FAB) cooperative group. Br J Haematol 33: 451-458, 1976.
23. Zintl F, Malke H, Reimann M, Domula M, Dorffel W, Eggers G, Exadaktylos P, Hilgenfeld E, Kotte W, Krause I, Kunert W, Mittler U, Mobius D, Reddemann H, Weinmann G, Weißbach G: Results with randomized BFM adopted studies for ALL therapy in childhood in east German countries. In: Acute Leukemias IV: Prognostic factors (T. Buchner G. Schellong W. Hiddemann J. Urbanitz and J. Ritter, Eds), p. 179-186, Springer Verlag, Berlin Heidelberg, 1993.
24. Sauerbrey A, Zintl F, Malke H, Reimann M, Maaser M, Domula M, Dorffel W, Eggers G, Exadaktylos P, Kotte W, Krause I, Mittler U. Mobius D, Reddemann H, Weißbach G, Weinmann G: Results and experience with a modified BFM-protocol for the treatment of relapsed childhood acute lymphoblastic leukemia in east Germany. Klin Padiatr 205: 281-284, 1993.
25. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1956.
26. Vramus HE, Lowell CA: Cancer genes and hematopoiesis. Blood 83: 5-9, 1994.
27. Yarbo JW: Oncogenes and cancer suppressor genes. Semin Oncol 8: 30-39, 1992.
28. Hangaishi A, Ogawa S, Imamura N, Miyawaki S, Miura Y, Uike N, Shimazaki C, Emi N, Takeyama K, Hirosawa S, Kamada N, Kobayashi Y, Takemoto Y, Kitani T, Toyama K, Ohtake S, Yazaki Y, Ueda R, Hirai H: Inactivation of multiple tumor suppressor genes involved in negative regulation of the cell cycle, MTS1/p161NK4A/CDKN2, MTS2/p151NK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 87: 4949-4958, 1996.
29. Kornblau SM, Xu HJX, Zhang W, Hu SX, Beran M, Smith TL, Hester J, Estey E, Benedict WF, Deisseroth AB: Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 84: 256-261, 1994.
30. Sauerbrey A, Stammler G, Zintl F, Volm M: Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukemia. BrJ Haematol 94: 99-104, 1996.
31. Volm M, Sauerbrey A, Stammler G, Zintl F: Detection of Fos, Jun and Ras in newly diagnosed childhood acute lymphoblastic leukemia by immunocytochemistry and PCR. Int J Oncol 4: 1251-1256, 1994.
32. Volm M, Efferth Th, Mattern J: Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res 12: 11-20, 1992.
33. Lipponen P, Eskelinen M, Syrjänen K: Expression of tumor-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. Br J Cancer 71: 863-867, 1995.
34. Pietiläinen T Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjänen K: Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer 31: 329-333, 1995.
35. Horton LE, Qian Y, Templeton DJ: G1 cyclin controls the retinoblastoma gene product regulation activity via upstream mechanisms. Cell Growth Differ 6: 395-407, 1995.
36. Goodrich DW, Wang NP, Qian YW, Lee EYHP, Lee WH: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67: 293-302, 1991.
37. Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J: Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol 15: 2600-2611, 1995.
38. Rosenberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A: PRAD1, a candidate BCL-1 oncogene: Mapping an expression in centrocyctic lymphoma. Proc Natl Acad Sci USA 88: 9638-9642, 1991.
39. CDKN2B genes in certain B cell non-Hodakin's lymphomas. Functional studies in a cell line(Granta 519). Leukemia 11: 64-72, 1997.
40. Uchimaru K, Taniguchi T, Yoshikawa M, Asano S, Arnold A, Fujita T, Motokura T: Detection of cyclin D1 (bcl-1. PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13:q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood 89: 965-974, 1497.
41. Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen N: A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 9: 1925-1929, 1994.
42. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma functions by ectopic expression of human cyclins. Cell 70: 993-1006, 1992.
43. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499-511, 1993.